Paper39242811
High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/MSI-H gastric cancer.
Kanoda R and 14 others. Sci Rep, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/MSI-H gastric cancer. Papers, record 39242811. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39242811
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/MSI-H gastric cancer.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stomach Neoplasms | Major topic |
| Membrane Proteins | Major topic |
| Signal Transduction | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Lymphocytes, Tumor-Infiltrating | Major topic |
| Tumor Microenvironment | Major topic |
| Microsatellite Instability | Major topic |
| Humans | |
| Male | |
| Female | |
| DNA Mismatch Repair | |
| Middle Aged | |
| Nucleotidyltransferases | |
| Gene Expression Regulation, Neoplastic | |
| Aged | |
| STING Protein | |
| Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 23K08177 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30173350 | Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. | Cell Mol Life Sci | 2018 | https://conductscience.org/library/papers/30173350 | PubMed |
| 2 | 28763795 | Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells. | Sci Immunol | 2017 | https://conductscience.org/library/papers/28763795 | PubMed |
| 3 | 37542528 | Down-regulation of stimulator of interferon genes (STING) expression and CD8+ T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer. | Gastric Cancer | 2023 | https://conductscience.org/library/papers/37542528 | PubMed |
| 4 | 34635662 | Immune cell infiltration signatures identified molecular subtypes and underlying mechanisms in gastric cancer. | NPJ Genom Med | 2021 | https://conductscience.org/library/papers/34635662 | PubMed |
| 5 | 38512518 | cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/38512518 | PubMed |
| 6 | 25079317 | Comprehensive molecular characterization of gastric adenocarcinoma. | Nature | 2014 | https://conductscience.org/library/papers/25079317 | PubMed |
| 7 | 25572843 | Positive feedback regulation of type I interferon by the interferon-stimulated gene STING. | EMBO Rep | 2015 | https://conductscience.org/library/papers/25572843 | PubMed |
| 8 | 35006429 | cGAS/STING: novel perspectives of the classic pathway. | Mol Biomed | 2020 | https://conductscience.org/library/papers/35006429 | PubMed |
| 9 | 28483787 | A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice. | Cancer Immunol Res | 2017 | https://conductscience.org/library/papers/28483787 | PubMed |
| 10 | 33479394 | PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms. | Sci Rep | 2021 | https://conductscience.org/library/papers/33479394 | PubMed |
| 11 | 21898388 | Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. | Int J Cancer | 2012 | https://conductscience.org/library/papers/21898388 | PubMed |
| 12 | 23890059 | Oncology meets immunology: the cancer-immunity cycle. | Immunity | 2013 | https://conductscience.org/library/papers/23890059 | PubMed |
| 13 | 26748708 | Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis. | Cell Rep | 2016 | https://conductscience.org/library/papers/26748708 | PubMed |
| 14 | 25959818 | Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. | Cell Rep | 2015 | https://conductscience.org/library/papers/25959818 | PubMed |
| 15 | 24737677 | Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. | J Surg Oncol | 2014 | https://conductscience.org/library/papers/24737677 | PubMed |
| 16 | 29844132 | Glycosyltransferase Gene Expression Identifies a Poor Prognostic Colorectal Cancer Subtype Associated with Mismatch Repair Deficiency and Incomplete Glycan Synthesis. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29844132 | PubMed |
| 17 | 35020204 | Cancer statistics, 2022. | CA Cancer J Clin | 2022 | https://conductscience.org/library/papers/35020204 | PubMed |
| 18 | 29367762 | Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production. | Oncogene | 2018 | https://conductscience.org/library/papers/29367762 | PubMed |
| 19 | 33846173 | Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33846173 | PubMed |
| 20 | 21930765 | Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. | J Exp Med | 2011 | https://conductscience.org/library/papers/21930765 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42852635 | cGAS‑STING pathway in digestive tract cancer: From molecular mechanisms to therapeutic applications (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42852635 | PubMed |
| 42828177 | Deep learning-based radiomics and pathomics for decoding tumor microenvironment and predicting immunotherapy outcomes in gastric cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42828177 | PubMed |
| 42596654 | cGAS-STING pathway activation drives the cold-to-hot tumor transition and sensitizes immunotherapy. | Cancer Biol Med | 2026 | https://conductscience.org/library/papers/42596654 | PubMed |
| 42552062 | "Yong" syndrome-cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42552062 | PubMed |
| 42459646 | Decoding the PTM code of cGAS-STING in gastric cancer: from innate DNA sensing to precision combination therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42459646 | PubMed |
| 41655160 | cGAS-STING Pathway in Gastrointestinal Malignancies: Mechanistic Insights and Translational Therapeutic Opportunities. | J Gastrointest Cancer | 2026 | https://conductscience.org/library/papers/41655160 | PubMed |
| 41295487 | In Situ Vaccination by Tumor Ablation: Principles and Prospects for Systemic Antitumor Immunity. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295487 | PubMed |
| 40991396 | Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in Cancer. | Cancer Res | 2025 | https://conductscience.org/library/papers/40991396 | PubMed |
| 40817248 | TRIM6 ablation reverses ICB resistance in MSS gastric cancer by unleashing cGAS-STING-dependent antitumor immunity. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40817248 | PubMed |
| 40643462 | Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway. | Cells | 2025 | https://conductscience.org/library/papers/40643462 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CGAS | 115004 | PubTator's text mining | https://conductscience.org/library/genes/115004 | NCBI Gene |
| STING1 | 340061 | PubTator's text mining | https://conductscience.org/library/genes/340061 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39242811
GET https://conductscience.org/api/papers/v1/39242811/references?page=2